Avalo Therapeutics Inc
NASDAQ:AVTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
US |
|
argenx SE
XBRU:ARGX
|
NL |
|
P
|
PepsiCo Inc
F:PEP
|
US |
|
OP Bancorp
NASDAQ:OPBK
|
US |
|
T
|
Tyson Foods Inc
XMUN:TF7A
|
US |
|
S
|
SPS Finquest Ltd
BSE:538402
|
IN |
|
A
|
Autodesk Inc
DUS:AUD
|
US |
Wall St Price Targets
AVTX Price Targets Summary
Avalo Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
AVTX is 48.25 USD with a low forecast of 34.34 USD and a high forecast of 63 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AVTX's stock price target?
Price Target
48.25
USD
According to Wall Street analysts, the average 1-year price target for
AVTX is 48.25 USD with a low forecast of 34.34 USD and a high forecast of 63 USD.